PhenoMx has taken aggressive measures to support global healthcare needs by developing a rapid CT screening protocol.
Submit an inquiry below and a member of our team will contact you as soon as possible.
In response to the ongoing global COVID-19 pandemic, PhenoMx has created the PhenoCHEST (TM) rapid CT screening protocol.
This new tool leverages non-invasive CT scanning, digital chest X-Rays and start-of-the-art Artificial Intelligence algorithms to rapidly score findings and characteristics associated with the presence of COVID-19.
PhenoCHEST (TM) has been developed using a limited real-world data set from patients infected with COVID-19 in both China and South Korea.
* PhenoCHEST is based on clinical images derived from equipment that has been cleared by respective regulatory authorities and government notified bodies. This tool is being provided to healthcare systems and clinicians on an investigational basis.
PhenoMx Co-Founder & CEO, Mark Punyanitya, joins This Week in Health Innovation to discuss what PhenoMx can do to contribute to the fight against the COVID-19 pandemic.
Rapidly determine your risk of exposure to the COVID-19 coronavirus.
Note: This information is not intended to replace the advice of a doctor or healthcare provider about diagnosis, treatment or potential outcomes. PhenoMx is not responsible for medical decisions that may be made based on the Risk Assessment since this tool is provided
FOR INFORMATIONAL PURPOSES ONLY